Check out $AVYA..this is going to squeeze hard.
maynall44
Posts
-
-
Check out $AVYA..this is going to squeeze hard.
-
$TBLT- sell that and buy and Check out $AVYA..this is going to squeeze hard.
-
Check out $AVYA..this is going to squeeze hard.
-
$JZ-I think this will eventually settle somewhere in the $20s. Company have very good revenue.
Check out $AVYA..this is going to squeeze hard.
-
$HSDT: This will be over $2.00 soon. Any positive news now can send it to the moon. Solid company. Hold..
-
$GCT - good entry. Added a few more. Looking for mid $70s.
-
$GCT-Most people still cannot buy. Webull screwed us today. They are going to joint Robinhood pretty soon.
-
$MEGL - A lot of people money just magically disappeared.
-
$SIGA- Wowwwwwwwww
-
$GEGR- What a piece of Sh$@t.
-
$GEGR- What a piece of Sh$@t.
-
$MULN- 600 miles per charge. Amazing!
I am still surprised that this stock is not at $20 to $30. -
Luna.x- I am going to hold on the my coins. I have seen some strange things happen in Crypto. I think the developers will come up with a decent fix. I will take the risk for a few hundred dollar. Fingers crossed!
-
#MULN: Most of these law firms that claim they’re filing suit on behalf of investors, are all full of shit. This is a money grab for these law firms. Investers makes zero to very little in these cases. In my opinion, this case will go no where just most of these most of these lawsuit.
-
$SBFM: Wow oh wow. This surprise me today. Waiting for pull back, never happen. This might be going for a moon shot.
-
$MULN: Just imagine if $AMC invested some of their $1.8 billion cash reserve into MULN! AMC are looking to diversify their investments MULN is a good opportunity them to get into the car ev battery business.
-
$ENSC:
-
$GLSI
STAFFORD, Texas--(BUSINESS WIRE)-- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that the Company will participate in the following interviews and conferences.
Today at 5:00 pm, the Company’s management team will be presenting two posters at the 2021 San Antonio Breast Cancer Symposium (SABCS) in person. The Company anticipates making the SABCS Phase IIb poster available on its website by the morning of December 9, exactly one year after the 2020 SABCS poster was published showing that no metastatic breast cancer recurrences were observed over 5 years of follow-up in HER2 positive patients who were fully treated. On December 9 at 2:20 pm ET, Snehal Patel, CEO of Greenwich LifeSciences, will appear as a featured guest in a live interview on TD Ameritrade Network's The Watch List with host Nicole Petallides to discuss the poster.
-
$GLSI- To promote a stock don’t mean you have to put another one down. $SLS
Just buy both of them and stop making a fool of yourself. ️
ILUS
KOSS
TBLT
HSDT
JZ
HSDT
GCT
GCT
MEGL
SIGA
GEGR
GEGR
MULN
LUNA.X
MULN
SBFM
MULN
ENSC
GLSI
GLSI